• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于甲氨蝶呤或复方口服避孕药对米非司酮与前列腺素阴道栓剂引产术后出血模式影响的试点研究。

A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary.

作者信息

Martin C W, Brown A H, Baird D T

机构信息

Department of Obstetrics and Gynaecology, University of Edinburgh, Scotland.

出版信息

Contraception. 1998 Aug;58(2):99-103. doi: 10.1016/s0010-7824(98)00072-9.

DOI:10.1016/s0010-7824(98)00072-9
PMID:9773264
Abstract

Although a combination of mifepristone and a prostaglandin is a safe, acceptable alternative to vacuum aspiration for inducing abortion in early pregnancy, the longer period of vaginal bleeding after medical abortion is a disadvantage. The present study investigated whether administration of the combined oral contraceptive pill (COC) or the injection of methotrexate at the time of abortion would shorten the period of vaginal bleeding after medical abortion. After having a medical abortion induced with mifepristone (200 mg) and 0.5 mg gemeprost pessary, 80 women were randomized to four groups of 20 women each; Group A, COC; Group B, control; Group C, 50 mg/m2 methotrexate; and Group D, placebo injection. There was no significant difference in the duration of bleeding between Groups A and B (median 14 and 17 days) or between Groups C and D (18 and 15 days), or in the amount of bleeding (4 days of heavy bleeding in each group). The first period occurred sooner in Group A who took the COC (median/range: 25/15-54 control group versus 32/16-46 days, p < 0.04). The administration of methotrexate was associated with a temporary elevation in liver enzyme concentration in one woman. It is concluded that women who wish to use COC can start immediately after medical abortion. Addition of methotrexate after abortion has no significant beneficial effect on patterns of bleeding and cannot be recommended.

摘要

虽然米非司酮和前列腺素联合使用是早期妊娠人工流产时一种安全、可接受的替代真空吸引术的方法,但药物流产后阴道出血时间较长是一个缺点。本研究调查了流产时服用复方口服避孕药(COC)或注射甲氨蝶呤是否会缩短药物流产后的阴道出血时间。在用米非司酮(200mg)和0.5mg吉美前列素阴道栓进行药物流产后,80名妇女被随机分为四组,每组20名妇女;A组,服用COC;B组,对照组;C组,50mg/m²甲氨蝶呤;D组,注射安慰剂。A组和B组之间(中位数分别为14天和17天)、C组和D组之间(分别为18天和15天)的出血持续时间以及出血量(每组均为4天大量出血)均无显著差异。服用COC的A组月经初潮出现得更早(中位数/范围:对照组为25/15 - 54天,A组为32/16 - 46天,p < 0.04)。有一名妇女注射甲氨蝶呤后出现肝酶浓度暂时升高。结论是,希望使用COC的妇女在药物流产后可立即开始服用。流产后加用甲氨蝶呤对出血模式无显著有益影响,不建议使用。

相似文献

1
A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary.一项关于甲氨蝶呤或复方口服避孕药对米非司酮与前列腺素阴道栓剂引产术后出血模式影响的试点研究。
Contraception. 1998 Aug;58(2):99-103. doi: 10.1016/s0010-7824(98)00072-9.
2
Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.米非司酮联合前列腺素阴道栓用于早期妊娠治疗性流产的引产
Lancet. 1987 Dec 19;2(8573):1415-8. doi: 10.1016/s0140-6736(87)91126-3.
3
Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.米索前列醇与宫颈扩张凝胶联合小剂量米非司酮用于引产的随机试验。
Hum Reprod. 1995 Jun;10(6):1521-7. doi: 10.1093/humrep/10.6.1521.
4
Induction of abortion in early pregnancy with mifepristone in conjunction with gemeprost.米非司酮联合吉美前列素用于早期妊娠流产引产
Acta Obstet Gynecol Scand. 1993 Jan;72(1):39-42. doi: 10.3109/00016349309013347.
5
Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost).使用米非司酮(RU 486)和前列腺素类似物(吉美前列素)进行早期流产诱导后的失血情况。
Contraception. 1989 Oct;40(4):439-47. doi: 10.1016/0010-7824(89)90051-6.
6
The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).米索前列醇在孕中期的堕胎效果。与米非司酮(RU486)预处理患者中吉美前列素的随机对照比较。
Hum Reprod. 1993 Oct;8(10):1744-6. doi: 10.1093/oxfordjournals.humrep.a137927.
7
Changes in the concentration of alpha-fetoprotein and placental hormones following two methods of medical abortion in early pregnancy.早期妊娠两种药物流产方法后甲胎蛋白和胎盘激素浓度的变化
Br J Obstet Gynaecol. 1993 Dec;100(12):1111-4. doi: 10.1111/j.1471-0528.1993.tb15175.x.
8
Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women.米非司酮(RU 486)联合前列腺素类似物用于早期妊娠的药物流产。对16369名女性进行的研究。
Acta Obstet Gynecol Scand. 1992 May;71(4):278-83. doi: 10.3109/00016349209021052.
9
Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost.闭经56天及以内女性的药物流产:米索前列醇(一种PGE1类似物)单用与米非司酮联合米索前列醇的比较
Br J Obstet Gynaecol. 1992 Jul;99(7):601-6. doi: 10.1111/j.1471-0528.1992.tb13830.x.
10
Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (gemeprost).孕早期单独使用抗孕激素RU486或与前列腺素类似物(吉美前列素)联合进行治疗性流产。
Contraception. 1986 Nov;34(5):459-68. doi: 10.1016/0010-7824(86)90055-7.

引用本文的文献

1
Medical methods for first trimester abortion.医学方法终止早期妊娠。
Cochrane Database Syst Rev. 2022 May 24;5(5):CD002855. doi: 10.1002/14651858.CD002855.pub5.
2
Subsequent placenta accreta after previous mifepristone-induced abortion: A case report.既往米非司酮诱导流产后发生的胎盘植入:一例报告。
World J Clin Cases. 2021 Nov 26;9(33):10244-10248. doi: 10.12998/wjcc.v9.i33.10244.
3
Systemic hormonal contraception initiation after abortion: A systematic review and meta-analysis.流产后开始全身性激素避孕:系统评价和荟萃分析。
Contraception. 2021 May;103(5):291-304. doi: 10.1016/j.contraception.2021.01.017. Epub 2021 Feb 3.
4
Immediate start of hormonal contraceptives for contraception.立即开始使用激素避孕药进行避孕。
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD006260. doi: 10.1002/14651858.CD006260.pub3.
5
Medical methods for first trimester abortion.孕早期人工流产的医学方法。
Cochrane Database Syst Rev. 2011 Nov 9;2011(11):CD002855. doi: 10.1002/14651858.CD002855.pub4.